CS
PVLA
Credit Suisse’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-68,940
| Closed | -$356K | – | 3728 |
|
|
2021
Q3 | $356K | Sell |
68,940
-7,743
| -10% | -$40K | ﹤0.01% | 3190 |
|
|
2021
Q2 | $294K | Sell |
76,683
-4,788
| -6% | -$18.4K | ﹤0.01% | 3286 |
|
|
2021
Q1 | $209K | Sell |
81,471
-9,524
| -10% | -$24.4K | ﹤0.01% | 3260 |
|
|
2020
Q4 | $227K | Buy |
90,995
+12,028
| +15% | +$30K | ﹤0.01% | 3210 |
|
|
2020
Q3 | $163K | Sell |
78,967
-2,735
| -3% | -$5.65K | ﹤0.01% | 3124 |
|
|
2020
Q2 | $253K | Buy |
81,702
+4,961
| +6% | +$15.4K | ﹤0.01% | 3023 |
|
|
2020
Q1 | $175K | Buy |
+76,741
| New | +$175K | ﹤0.01% | 3084 |
|
|
2019
Q4 | – | Sell |
-18,989
| Closed | -$64K | – | 3592 |
|
|
2019
Q3 | $64K | Buy |
+18,989
| New | +$64K | ﹤0.01% | 3339 |
|
|
2019
Q2 | – | Sell |
-12,701
| Closed | -$42K | – | 3510 |
|
|
2019
Q1 | $42K | Buy |
+12,701
| New | +$42K | ﹤0.01% | 3320 |
|
|
2018
Q3 | – | Sell |
-13,687
| Closed | -$69K | – | 3444 |
|
|
2018
Q2 | $69K | Sell |
13,687
-1,898
| -12% | -$9.57K | ﹤0.01% | 3408 |
|
|
2018
Q1 | $106K | Buy |
15,585
+5,404
| +53% | +$36.8K | ﹤0.01% | 3365 |
|
|
2017
Q4 | $77K | Sell |
10,181
-12,959
| -56% | -$98K | ﹤0.01% | 3371 |
|
|
2017
Q3 | $133K | Buy |
23,140
+12,644
| +120% | +$72.7K | ﹤0.01% | 3547 |
|
|
2017
Q2 | $54K | Buy |
+10,496
| New | +$54K | ﹤0.01% | 3384 |
|